Rheumatoid Arthritis Clinical Trials in Chicago

Showing 741-760 of 3,348 trials

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT02199665

This phase I trial studies the side effects and best dose of selinexor and carfilzomib when given together with dexamethasone in treating patients with multiple myeloma that has returned or does not respond to treatment. Drugs used in chemotherapy, such as selinexor and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be a better treatment for multiple myeloma.

Refractory Multiple Myeloma

University of Chicago52 participantsStarted Jun 2014

Scottsdale, Arizona, United States • Chicago, Illinois, United States • Ann Arbor, Michigan, United States +2 more locations

Active Not Recruiting2.2 miles

OCS Heart Perfusion Post-Approval Registry

NCT05047068

The objective of this post-approval registry is to provide additional real-world evidence of the performance of the OCS Heart System to preserve DBD and DCD donor hearts.

Transplant

TransMedics350 participantsStarted Sep 2021

Los Angeles, California, United States • Palo Alto, California, United States • San Francisco, California, United States +24 more locations

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

OCS Heart Perfusion Post-Approval Registry

Rheumatoid Arthritis Trials in Other Cities

Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Add-on Reparixin in Adult Patients With ARDS

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head

Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty

ZILRETTA in Subjects With Shoulder Osteoarthritis

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Stryker's Surgeon iD Mandible Reconstruction Plates: A Retrospective Post Market Follow Up

Other Conditions in Chicago